In continuation of the company's announcement dated 2 November 2011 concerning a planned share repurchase programme, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2011 owned 24,440,186 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 24,440,186 or 4.21% of the total share capital.

Media:
Investors:
Anne Margrethe Hauge
Klaus Bülow Davidsen
Tel: (+45) 4442 3450
Tel: (+45) 4442 3176
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Lars Borup Jacobsen
Tel: (+45) 3075 3479
In North America:
Ken Inchausti
Jannick Lindegaard
Tel: (+1) 609 514 8316
Tel: (+1) 609 786 4575

Company Announcement no 1 / 2012